1.80
price down icon1.09%   -0.03
 
loading
Medicinova Inc stock is traded at $1.80, with a volume of 79,807. It is down -1.09% in the last 24 hours and up +0.00% over the past month. MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
See More
Previous Close:
$1.83
Open:
$1.79
24h Volume:
79,807
Relative Volume:
1.07
Market Cap:
$88.29M
Revenue:
-
Net Income/Loss:
$-9.51M
P/E Ratio:
-7.20
EPS:
-0.25
Net Cash Flow:
$-10.96M
1W Performance:
+18.30%
1M Performance:
+0.00%
6M Performance:
+27.46%
1Y Performance:
+1.69%
1-Day Range:
Value
$1.70
$1.825
1-Week Range:
Value
$1.70
$2.55
52-Week Range:
Value
$1.12
$2.55

Medicinova Inc Stock (MNOV) Company Profile

Name
Name
Medicinova Inc
Name
Phone
858-373-1500
Name
Address
4275 EXECUTIVE SQUARE, LA JOLLA, CA
Name
Employee
13
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
MNOV's Discussions on Twitter

Compare MNOV with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
MNOV 1.81 88.29M 0 -9.51M -10.96M -0.25
VRTX 467.37 119.83B 10.63B -479.80M -1.35B 13.33
REGN 760.78 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 564.61 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 230.58 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.64 24.08B 3.30B -501.07M 1.03B 11.54

Medicinova Inc Stock (MNOV) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-10-21 Initiated Maxim Group Buy
Mar-25-19 Resumed B. Riley FBR Buy
Mar-28-18 Initiated B. Riley FBR, Inc. Buy
Apr-18-17 Initiated Credit Suisse Outperform
Jan-04-13 Reiterated Ladenburg Thalmann Buy
May-24-12 Downgrade MLV & Co Buy → Hold
Oct-18-11 Reiterated MLV Capital Buy
Jun-22-11 Initiated Global Hunter Securities Buy
May-12-10 Initiated Wedbush Outperform
Nov-12-08 Reiterated Ladenburg Thalmann Buy
May-15-08 Initiated Rodman & Renshaw Mkt Outperform
Jul-09-07 Initiated Punk, Ziegel & Co Buy
View All

Medicinova Inc Stock (MNOV) Latest News

pulisher
Nov 17, 2024

StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV) - Defense World

Nov 17, 2024
pulisher
Nov 15, 2024

MediciNova (NASDAQ:MNOV) Coverage Initiated at StockNews.com - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

MediciNova Receives Notice of Allowance from United States - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

MediciNova Secures Key Patent for Diabetes Treatment MN-001 Through 2042 | MNOV Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

MediciNova: Q3 Earnings Snapshot - New Haven Register

Nov 14, 2024
pulisher
Nov 13, 2024

3 US Penny Stocks With Market Caps Over $40M To Consider - Simply Wall St

Nov 13, 2024
pulisher
Nov 12, 2024

MediciNova stock hits 52-week high at $2.17 amid growth - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

MediciNova stock hits 52-week high at $2.17 amid growth By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 11, 2024

MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis - The Manila Times

Nov 11, 2024
pulisher
Nov 11, 2024

MediciNova Secures Major Settlement from Sanofi-Novartis Litigation, Boosts Clinical Pipeline | MNOV Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 11, 2024

Idiopathic Pulmonary Fibrosis Management Market Share and Size Report 2024-2031 - InsightAce Analytic

Nov 11, 2024
pulisher
Nov 07, 2024

MediciNova (NASDAQ:MNOV shareholders incur further losses as stock declines 11% this week, taking five-year losses to 80% - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

MediciNova (NASDAQ:MNOV) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at StockNews.com - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

TSX Buyback Index (TXBB) QuotePress Release - The Globe and Mail

Nov 06, 2024
pulisher
Nov 04, 2024

Idiopathic Pulmonary Fibrosis Market Is Booming Worldwide - openPR

Nov 04, 2024
pulisher
Oct 30, 2024

MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com - Defense World

Oct 30, 2024
pulisher
Oct 30, 2024

StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV) - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

MediciNova (NASDAQ:MNOV) Shares Cross Above Two Hundred Day Moving Average – Should You Sell? - Defense World

Oct 30, 2024
pulisher
Oct 30, 2024

MediciNova (NASDAQ:MNOV) Stock Price Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Oct 30, 2024
pulisher
Oct 25, 2024

Clean Harbors (CLH-N) QuotePress Release - The Globe and Mail

Oct 25, 2024
pulisher
Oct 23, 2024

MediciNova Announces Update of Phase 2/3 Clinical Trial of - GlobeNewswire

Oct 23, 2024
pulisher
Oct 23, 2024

MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium) - StockTitan

Oct 23, 2024
pulisher
Oct 22, 2024

MediciNova (NASDAQ:MNOV) Research Coverage Started at StockNews.com - Defense World

Oct 22, 2024
pulisher
Oct 22, 2024

MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews.com - MarketBeat

Oct 22, 2024
pulisher
Oct 17, 2024

TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail

Oct 17, 2024
pulisher
Oct 16, 2024

MediciNova, Inc. (NASDAQ:MNOV) Shares Sold by Dimensional Fund Advisors LP - Defense World

Oct 16, 2024
pulisher
Oct 08, 2024

Type 1 Diabetes Market Report 2034: Epidemiology Data, Pipeline - openPR

Oct 08, 2024
pulisher
Oct 07, 2024

MediciNova (NASDAQ:MNOV) shareholders have endured a 73% loss from investing in the stock five years ago - Yahoo Finance

Oct 07, 2024
pulisher
Oct 06, 2024

MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com - MarketBeat

Oct 06, 2024
pulisher
Sep 30, 2024

MNOV: MN-166 to be Evaluated in NIH-Sponsored Expanded Access Trial in ALS - Smartkarma

Sep 30, 2024
pulisher
Sep 30, 2024

MNOVMedicinova, Inc. Latest Stock News & Market Updates - StockTitan

Sep 30, 2024
pulisher
Sep 30, 2024

Short Interest in MediciNova, Inc. (NASDAQ:MNOV) Rises By 19.3% - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

MediciNova to Support NIH-Funded Expanded Access Clinical - GlobeNewswire

Sep 30, 2024
pulisher
Sep 30, 2024

MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS) - StockTitan

Sep 30, 2024
pulisher
Sep 28, 2024

MediciNova (NASDAQ:MNOV) Stock Crosses Above 200-Day Moving Average of $1.42 - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Amyotrophic Lateral Sclerosis Pipeline Insights, Treatment Drugs, Clinical Trials, and Companies 2024 - The Globe and Mail

Sep 27, 2024
pulisher
Sep 25, 2024

MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Stockhouse Publishing

Sep 25, 2024
pulisher
Sep 25, 2024

Insigneo Advisory Services LLC Has $6.10 Million Stock Position in Mastercard Incorporated (NYSE:MA) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Intech Investment Management LLC Takes Position in MSA Safety Incorporated (NYSE:MSA) - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Minerals Technologies (NYSE:MTX) Upgraded at StockNews.com - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Monroe Capital (NASDAQ:MRCC) Stock Crosses Above 200 Day Moving Average of $7.49 - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

MARXU stock soars to all-time high of $12.15 amid market optimism - Investing.com Australia

Sep 25, 2024
pulisher
Sep 24, 2024

Marcus (NYSE:MCS) Upgraded by StockNews.com to Hold - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Mistras Group senior EVP sells over $349k in company stock - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

Contact Levi & Korsinsky by September 24, 2024 Deadline to Join Class Action Against MacroGenics, Inc.(MGNX) - Stockhouse Publishing

Sep 24, 2024
pulisher
Sep 24, 2024

Summit Trail Advisors LLC Buys 403 Shares of Moderna, Inc. (NASDAQ:MRNA) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

MacroGenics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationMGNX - Longview News-Journal

Sep 24, 2024
pulisher
Sep 23, 2024

MasterBrand (NYSE:MBC) Hits New 52-Week High at $19.10 - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

ProShare Advisors LLC Sells 43,073 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Mutual of America Capital Management LLC Cuts Position in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World

Sep 23, 2024

Medicinova Inc Stock (MNOV) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$18.94
price up icon 3.39%
$75.94
price down icon 0.01%
$39.03
price up icon 6.21%
$360.25
price down icon 0.96%
$187.60
price down icon 1.35%
$99.70
price down icon 0.06%
Cap:     |  Volume (24h):